Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)

Completed · Phase 3

Conditions studied: Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases

In brief

The study is designed as a Phase III, randomized, open label, multicenter, prospective, comparative trial of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells (PBSC) versus marrow from unrelated donors for transplantation in patients with hematologic malignancies. Recipients will be stratified by transplant center and disease risk and will be randomized to either the PBSC or marrow arm in a 1:1 ratio.

Key facts

Study ID
NCT00075816
Run by
Medical College of Wisconsin
People needed
551
Starts
2004-01-01
Expected to finish
2014-04-01
Last updated by the study team
2023-01-04

Who can join

Age: any, up to 66. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.